Treatment for millions of people with type 2 diabetes should be more personalised, with greater access to newer medicines, ...

The side effect is rare, according to a new study, but is also the subject of multiple lawsuits, including two filed by Long ...

Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ...

The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...

Viking Therapeutics said Tuesday its experimental weight-loss pill helped patients lose 12.2% of their body weight in a ...

Using GLP-1 drugs for weight loss is considered safe but can come with a loss of lean muscle mass. It’s crucial to do ...

Novo Nordisk is teaming up with GoodRx to offer Wegovey and Ozempic for a flat price of $499 a month. Top Air Force general ...

(Reuters) -Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks ...

Republican leaders pushed back on the DHHS approach. They also tied the dispute to broader state budget negotiations.

FMP, the University of Oxford, and the University of Birmingham have developed a novel imaging approach to track how popular ...

Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...